A low concentration of curcumin has been shown to potently reduce the proliferative and invasive activity of androgen-independent prostate cancer cells by interfering with the CDK-cyclin, the Akt-mTOR pathway, and integrin-related signaling. This evidence concerns the gene AKT1 and prostate cancer.